May 1, 2018 / 11:40 AM / 2 months ago

BRIEF-Spectrum Pharmaceuticals Enters Into A Next-Generation Sequencing Companion Diagnostic Partnership With Thermo Fisher Scientific

May 1 (Reuters) - Spectrum Pharmaceuticals Inc:

* SPECTRUM PHARMACEUTICALS ENTERS INTO A NEXT-GENERATION SEQUENCING COMPANION DIAGNOSTIC PARTNERSHIP WITH THERMO FISHER SCIENTIFIC

* SPECTRUM PHARMACEUTICALS INC - ENTERED INTO AN AGREEMENT WITH THERMO FISHER SCIENTIFIC

* SPECTRUM PHARMACEUTICALS - AGREEMENT TO LEVERAGE ONCOMINE DX TARGET TEST AS COMPANION DIAGNOSTIC FOR SPECTRUM'S NOVEL PAN-HER INHIBITOR POZIOTINIB Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below